Dr Bożena Walewska-Zielecka becomes new Medical Director and joins the Medicover Board

Dr Bożena Walewska-Zielecka becomes new Medical Director and joins the Medicover Board

Published

In June of this year, Dr Bożena Walewska-Zielecka was appointed to the Management Board of Medicover Sp. z o.o. and took over the post of Medical Director at Medicover. In her new role she will be responsible for medical quality, occupational medicine, prevention standards and the quality and risk management system, among others.

Dr Bożena Walewska-Zielecka became a new member of the Management Board of Medicover Sp. z o.o. At the same time, she assumed the position of Medical Director. Previously, she served as Deputy Clinical Director. She has been with Medicover since 1995.

The many years of experience gained at our company guarantees an excellent understanding of its functioning, priorities and key needs. Dr Bożena Walewska-Zielecka’s knowledge of Medicover combined with her medical and managerial experience will support the effective development of her department, 

comments Mirosław Suszek, Vice President of the Management Board, Director of Operations and Medical Division at Medicover Polska.

Bożena Walewska-Zielecka holds a PhD degree in medical sciences, is a pathologist, travel medicine physician and a specialist in liver disease. She also gained broad experience as a lecturer and researcher at Warsaw Medical University.
At the same time, Dr Piotr Soszyński took over the newly created position of Director of Medical Systems. He will be responsible for the maintenance and development of medical systems, supervising authorisations and access to the systems, as well as information security, including protecting medical information, along with the necessary adaptations to the new EU legal requirements, and cooperation with other innovation development teams.

Copy as a Plain Text

Share

Related Stories
Iwona Pokwicka is the new Vice President of the Board of Medicover sp. z o.o and Director of Operations for our Clinic Business

ago

In January, Iwona Pokwicka was appointed Vice President of Medicover sp. z o.o. and Director of Operations in Medicover’s clinic business. In this position, she will be responsible for the functioning of Medicover medical clinics throughout Poland.
Leading orthopaedic clinic Rehasport at the Medicover Hospital

ago

Professional medical help for injuries, accidents and contusions, comprehensive treatment and rehabilitation under the supervision of outstanding specialists who on a daily basis ensure the fitness of the biggest sport stars – available for patients at the Medicover Hospital in Warsaw’s Wilanów. The Rehasport Clinic, liaised with Medicover, is one of the four leading centres in Poland specializing in orthopaedics, rehabilitation and sports medicine. Professionalism and high quality are confirmed by international awards and the trust of many outstanding athletes.
E-health is much more than online prescriptions

ago

From digital self-care through virtual doctor appointments to remote examinations. E-health offers a wide range of possibilities. According to experts, the Internet and telemedicine can be used at any stage of treatment – technology is not a barrier these days. However, how do we develop the potential of remote solutions in order for them to be effective, useful and safe for the patient? What is the priority for medical service providers today? What changes can we expect in the coming years?
Protect yourself against cancer – take a genetic predisposition test!

ago

Over the next few years, cancer will become number one cause of death in our country. At present, nearly 157,000 Poles are diagnosed with malignant tumours every year and approximately 95,000 of them die. But contemporary medicine makes it possible to detect genes which may increase the risk of cancer development. Genetic predisposition tests are available, for instance, in the Medicover Medical Centre at Aleje Jerozolimskie 96.

Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer

Medicover Polska is testing the ColonFlag modern solution that will allow to effectively identify patients at risk for colorectal cancer. The tool determines the risk of intestinal lesions by further analysing the results of a commonly performed blood test. The pilot project is being developed in collaboration with Medial EarlySign, an Israeli company that creates machine-learning systems in the area of data-driven medicine.